Loading...
Nimotuzumab Combined with Induction Chemotherapy and Concurrent Chemoradiotherapy in Unresectable Locally Advanced Hypopharyngeal Carcinoma: A Single Institution Experience in China
OBJECTIVE: To investigate the curative and adverse effects (AEs) of additional use of nimotuzumab combined with induction chemotherapy and concurrent chemoradiotherapy in unresectable locoregionally advanced hypopharyngeal carcinoma. PATIENTS AND METHODS: We retrospectively evaluated 36 patients wit...
Na minha lista:
| Udgivet i: | Cancer Manag Res |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7227783/ https://ncbi.nlm.nih.gov/pubmed/32494195 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S248392 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|